Connection

ANITA DESWAL to Chronic Disease

This is a "connection" page, showing publications ANITA DESWAL has written about Chronic Disease.
Connection Strength

0.248
  1. Noncardiac Comorbidities in Chronic?Heart Failure: More Is Worse, What Else Do We Know? JACC Heart Fail. 2023 10; 11(10):1377-1379.
    View in: PubMed
    Score: 0.144
  2. Anti-angiotensin therapy: new perspectives. Cardiol Clin. 2007 Nov; 25(4):573-80; vi-vii.
    View in: PubMed
    Score: 0.049
  3. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578.
    View in: PubMed
    Score: 0.023
  4. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.016
  5. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.